Metabolism of lipid mediators in human eosinophils

Chemical Immunology

Volumn 76, Issue , 2000, Pages 77-98

  Triggiani, Massimo ^a   Calabrese, Cecilia ^a   Granata, Francescopaolo ^a   Gentile, Marco ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; EOSINOPHIL CATIONIC PROTEIN; ICOSANOID; LEUKOTRIENE C4; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

ALLERGIC REACTION; ANAPHYLAXIS; ASTHMA; CELL METABOLISM; CHEMOTAXIS; EOSINOPHIL; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0034055695     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058779     Document Type: Review

References (29)

1. Barnes PJ, Chung KF, Page CP: Inflammatory mediators and asthma. Pharmacol Rev 1988;40:49-84.
2. Henderson WR: The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-697.
3. Marone G (ed): Human Basophils and Mast Cells: Biological Aspects. Basel, Karger, 1995.
4. Holtzman MJ: Arachidonic acid metabolism. Am Rev Respir Dis 1991;143:188-203.
5. Snyder F: Platelet-activating factor and its analogs: Metabolic pathways and related intracellular processes. Biochim Biophys Acta 1995;1254:231-249.
6. Chilton FH, Ellis JM, Olson SC, Wykle RL: 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocoline: A common source of platelet-activating factor and arachidonate in the human polymorphonuclear leukocytes. J Biol Chem 1984;259:12014-12019.
7. Chilton FH: Platelet activating factor: synthesis, metabolism, and relationship to arachidonate products; in Henson PM, Murphy RC (eds): Handbook of Inflammation, vol 6: Mediators of the Inflammatory Process. Amsterdam, Elsevier Science Publishers BV (Biomedical Division), 1989, pp 77-112.
8. 2. J Biol Chem 1994;269:13057-13060.
9. MacDonald JIS, Sprecher H: Phospholipid fatty acid remodeling in mammalian cells. Biochim Biophys Acta 1991;1084:105-121.
10. Waku K: Origins and fates of fatty acyl-CoA esters. Biochim Biophys Acta 1992;1124:101-111.
11. Chilton FH, Fonteh AN, Surette ME, Triggiani M, Winkler JD: Control of arachidonate levels within inflammatory cells. Biochim Biophys Acta 1996;1299:1-15.
12. Weller PF: The immunobiology of eosinophils. N EngI J Med 1991;324:1110-1118.
13. Butterfield JH, Leiferman KM: Eosinophil-associated disease; in Smith H, Cook RM (eds): Immunopharmacology of Eosinophils. London, Academic Press, 1993, pp 152-192.
14. Busse WW, Sedgwick JB, Jarjour NN, Calhoun WJ: Eosinophils and basophils in allergic airway inflammation. J Allergy Clin Immunol 1994;94:1250-1254.
15. Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Ming Lee W, Kelly EAB, Gern JE: Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998;160:1279-1284.
16. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW: CDS T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999;162:4207-4211.
17. Lee T-C, Malone B, Wasserman SI, Fitzgerald V, Snyder F: Activities of enzymes that metabolize platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocoline) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun 1982;105:1303-1308.
18. 4. Proc Natl Acad Sci USA 1983;80:7626-7630.
19. Owen WF, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF: Synthesis and release of leukotriene C, by human eosinophils. J Immunol 1987;138:532-538.
20. Cromwell O, Wardlaw AJ, Champion A, Moqbel R, Osei D, Kay AB: IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol 1990;154:3862-3868.
21. 4 in response to FMLP. J Clin Invest 1991;87:1958-1963.
22. 4 by human eosinophils. J Biol Chem 1989;264:12885-12889.
23. 4 increase the release of mucus from human airway in vitro. Am Rev Respir Dis 1982;126:449-451.
24. 4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986;315-480-484.
25. 4 in man. Int J Clin Lab Res 1997;27:178-184.
26. Morita E, Schroder JM, Christophers E: Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid. J Immunol 1990;144:1893-1990.
27. Morita E, Schroder JM, Christophers E: Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils. Scand J Jmmunol 1990;32:497-502.
28. 2 and E-series prostaglandins. J Immunol 1990;144:3489-3497.
29. Kroegel C, Matthys H: Platelet activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. Immunology 1993;78:279-285.